What is the target price for 23andMe stock?
May 06, 2022 · MET-E support price is $25.03 and resistance is $25.43 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MET-E stock will trade within this expected range on the day.
Who is the CEO of MetLife Inc (met)?
Find the latest MetLife, Inc. (MET) stock quote, history, news and other vital information to help you with your stock trading and investing.
How much is a share of CME worth?
May 03, 2022 · MetLife Inc. 1.57 2.92 USD 2015 MetLife Inc. 1.32 3.06 USD 2015 MetLife Inc. 1.48
When does CME Group release its next quarterly earnings announcement?
Find the latest MetLife, Inc. (MET-PA) stock quote, history, news and other vital information to help you with your stock trading and investing.
See more
Nov 02, 2020 · Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. MetLife, Inc. 5.625 NCUM PFD E (MET.PE) Stock Price Today, Quote & News | Seeking Alpha
What symbol and exchange does MetLife, Inc. Depositary shares, each representing a 1/1000th interest in a share of the Issuera??s 5.625% Non-Cumulative Preferred Stock, Series E. stock trade?
MetLife, Inc. Depositary shares, each representing a 1/1000th interest in a share of the Issuera??s 5.625% Non-Cumulative Preferred Stock, Series E...
What is MetLife, Inc. Depositary shares, each representing a 1/1000th interest in a share of the Issuera??s 5.625% Non-Cumulative Preferred Stock, Series E. stock price doing today?
As of March 11, 2022, MET-E stock price declined to $25.51 with 31,691 million shares trading.
How much is MetLife, Inc. Depositary shares, each representing a 1/1000th interest in a share of the Issuera??s 5.625% Non-Cumulative Preferred Stock, Series E. worth?
MET-E has a market cap of $0.00. This is considered a Sub-Micro Cap stock.
What is the highest and lowest price MetLife, Inc. Depositary shares, each representing a 1/1000th interest in a share of the Issuera??s 5.625% Non-Cumulative Preferred Stock, Series E. traded in the last 3 year period?
In the last 3 years, MET-E stock traded as high as $28.34 and as low as $14.45.
Is MetLife, Inc. Depositary shares, each representing a 1/1000th interest in a share of the Issuera??s 5.625% Non-Cumulative Preferred Stock, Series E. (MET-E) a good investment?
MET-E stock has underperformed the market in the last year with a return of +0.6%, while SPY returned +8.2%. This...
What is the support and resistance for MetLife, Inc. Depositary shares, each representing a 1/1000th interest in a share of the Issuera??s 5.625% Non-Cumulative Preferred Stock, Series E. (MET-E) stock price?
MET-E support price is $25.37 and resistance is $25.72 (based on 1 day standard deviation move). This means that using the...
What is MetLife Holdings?
What is MetLife insurance?
The MetLife Holdings segment consists of operations relating to products and businesses, such as variable, universal, term and whole life insurance, variable, fixed and index-linked annuities, long-term care insurance, as well as the assumed variable annuity guarantees.
Is 23andMe a buy right now?
MetLife, Inc. provides insurance and financial services to individual and institutional customers. It offers life insurance, annuities, automobile and homeowner's insurance and retail banking services to individuals as well as group insurance, reinsurance and retirement and savings products and services.
What stocks does MarketBeat like better than 23andMe?
2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for 23andMe in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" 23andMe stock.#N#View analyst ratings for 23andMe or view top-rated stocks.
When is 23andMe's next earnings date?
Wall Street analysts have given 23andMe a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but 23andMe wasn't one of them.
How were 23andMe's earnings last quarter?
23andMe is scheduled to release its next quarterly earnings announcement on Friday, November 12th 2021.#N#View our earnings forecast for 23andMe.
What guidance has 23andMe issued on next quarter's earnings?
23andMe Holding Co. (NASDAQ:ME) released its earnings results on Friday, August, 13th. The company reported ($0.25) earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of ($0.57) by $0.32. The business had revenue of $59.24 million for the quarter.#N#View 23andMe's earnings history.
What price target have analysts set for ME?
23andMe issued an update on its FY 2022 earnings guidance on Friday, September, 10th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $250 million-$260 million.
Who are some of 23andMe's key competitors?
2 equities research analysts have issued 12-month price targets for 23andMe's shares. Their forecasts range from 12.00 to 13.00. On average, they anticipate 23andMe's stock price to reach 12.50 in the next year.
Is CME Group a buy right now?
Some companies that are related to 23andMe include Zai Lab (ZLAB), CureVac (CVAC), Maravai LifeSciences (MRVI), Ono Pharmaceutical (OPHLF), Dr.
What stocks does MarketBeat like better than CME Group?
14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CME Group in the last twelve months. There are currently 2 sell ratings, 8 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" CME Group stock.
When is CME Group's next earnings date?
Wall Street analysts have given CME Group a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but CME Group wasn't one of them.
How were CME Group's earnings last quarter?
CME Group is scheduled to release its next quarterly earnings announcement on Wednesday, October 27th 2021.#N#View our earnings forecast for CME Group.
How has CME Group's stock been impacted by COVID-19?
CME Group Inc. (NASDAQ:CME) announced its quarterly earnings results on Wednesday, July, 28th. The financial services provider reported $1.64 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.59 by $0.05.
How often does CME Group pay dividends? What is the dividend yield for CME Group?
CME Group's stock was trading at $194.6750 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, CME shares have increased by 1.0% and is now trading at $196.70.#N#View which stocks have been most impacted by COVID-19.
Is CME Group a good dividend stock?
CME Group announced a quarterly dividend on Thursday, August 5th. Investors of record on Friday, September 10th will be paid a dividend of $0.90 per share on Monday, September 27th. This represents a $3.60 dividend on an annualized basis and a yield of 1.83%. The ex-dividend date is Thursday, September 9th.#N#View CME Group's dividend history.
